Department of General Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhizaoju Road, Shanghai, 200011, China.
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lipids Health Dis. 2024 Apr 29;23(1):124. doi: 10.1186/s12944-024-02105-0.
Obesity affects approximately 800 million people worldwide and may contribute to various diseases, especially cardiovascular and cerebrovascular conditions. Fat distribution and content represent two related yet distinct axes determining the impact of adipose tissue on health. Unlike traditional fat measurement indices, which often overlook fat distribution, the Chinese visceral adiposity index (CVAI) is a novel metric used to assess visceral fat accumulation and associated health risks. Our objective is to evaluate its association with the risk of cardiovascular and cerebrovascular diseases.
A nationwide longitudinal study spanning 9 years was conducted to investigate both the effects of baseline CVAI levels (classified as low and high) and dynamic changes in CVAI over time, including maintenance of low CVAI, transition from low to high, transition from high to low, and maintenance of high CVAI. Continuous scales (restricted cubic spline curves) and categorical scales (Kaplan-Meier curves and multivariable Cox regression analyses) were utilized to evaluate the relationship between CVAI and cardiovascular and cerebrovascular diseases. Furthermore, subgroup analyses were conducted to investigate potential variations.
Totally 1761 individuals (22.82%) experienced primary outcomes among 7717 participants. In the fully adjusted model, for each standard deviation increase in CVAI, there was a significant increase in the risk of primary outcomes [1.20 (95%CI: 1.14-1.27)], particularly pronounced in the high CVAI group [1.38 (95%CI: 1.25-1.54)] compared to low CVAI group. Regarding transition patterns, individuals who consistently maintained high CVAI demonstrated the highest risk ratio compared to those who consistently maintained low CVAI [1.51 (95%CI: 1.31-1.74)], followed by individuals transitioning from low to high CVAI [1.22 (95% CI: 1.01-1.47)]. Analysis of restricted cubic spline curves indicated a positive dose-response relationship between CVAI and risk of primary outcomes (p for non-linear = 0.596). Subgroup analyses results suggest that middle-aged individuals with high CVAI face a notably greater risk of cardiovascular and cerebrovascular diseases in contrast to elderly individuals [1.75 (95% CI: 1.53-1.99)].
This study validates a significant association between baseline levels of CVAI and its dynamic changes with the risk of cardiovascular and cerebrovascular diseases. Vigilant monitoring and effective management of CVAI significantly contribute to early prevention and risk stratification of cardiovascular and cerebrovascular diseases.
肥胖影响着全球约 8 亿人,并可能导致各种疾病,尤其是心血管和脑血管疾病。脂肪分布和含量代表着两个相关但又不同的轴,决定了脂肪组织对健康的影响。与传统的脂肪测量指标不同,后者往往忽略了脂肪分布,中国内脏脂肪指数(CVAI)是一种新的指标,用于评估内脏脂肪堆积和相关的健康风险。我们的目的是评估其与心血管和脑血管疾病风险的关联。
进行了一项为期 9 年的全国性纵向研究,以研究基线 CVAI 水平(低和高分类)和 CVAI 随时间的动态变化的影响,包括低 CVAI 的维持、从低到高的转变、从高到低的转变以及高 CVAI 的维持。使用连续尺度(受限立方样条曲线)和分类尺度(Kaplan-Meier 曲线和多变量 Cox 回归分析)评估 CVAI 与心血管和脑血管疾病之间的关系。此外,还进行了亚组分析以探讨潜在的变化。
在 7717 名参与者中,共有 1761 人(22.82%)发生了主要结局。在完全调整模型中,CVAI 每增加一个标准差,主要结局的风险就会显著增加[1.20(95%CI:1.14-1.27)],在高 CVAI 组中更为明显[1.38(95%CI:1.25-1.54)],与低 CVAI 组相比。关于转变模式,与持续保持低 CVAI 的个体相比,持续保持高 CVAI 的个体的风险比最高[1.51(95%CI:1.31-1.74)],其次是从低到高 CVAI 转变的个体[1.22(95%CI:1.01-1.47)]。受限立方样条曲线分析表明,CVAI 与主要结局风险之间存在正剂量-反应关系(p 非线性=0.596)。亚组分析结果表明,与老年个体相比,中年高 CVAI 个体患心血管和脑血管疾病的风险明显更高[1.75(95%CI:1.53-1.99)]。
本研究验证了基线 CVAI 水平及其与心血管和脑血管疾病风险的动态变化之间存在显著关联。对 CVAI 的密切监测和有效管理对心血管和脑血管疾病的早期预防和风险分层具有重要意义。